Antriksh Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-12-2024
- Paid Up Capital ₹ 0.10 M
as on 23-12-2024
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Ebitda 0.33%
(FY 2022)
- Net Worth -188.29%
(FY 2022)
- Total Assets -6.77%
(FY 2022)
About Antriksh Pharmaceuticals
The Corporate was formerly known as Antriksh Hardware Solutions Private Limited. The Company is engaged in the Professional Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Deepanshu Rao and Champa Devi serve as directors at the Company.
- CIN/LLPIN
U74110DL2015PTC283782
- Company No.
283782
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Aug 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Antriksh Pharmaceuticals?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Deepanshu Rao | Director | 07-Aug-2015 | Current |
Champa Devi | Director | 03-May-2017 | Current |
Financial Performance of Antriksh Pharmaceuticals.
Antriksh Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 188.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss | |||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Antriksh Pharmaceuticals?
In 2017, Antriksh Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Antriksh Coal Private LimitedActive 9 years 5 months
Deepanshu Rao and Champa Devi are mutual person
- Antriksh Skyheight Private LimitedActive 9 years 5 months
Deepanshu Rao and Champa Devi are mutual person
- Antriksh Realcon Private LimitedActive 9 years 5 months
Deepanshu Rao and Champa Devi are mutual person
- Antriksh E Homes Private LimitedActive 9 years 5 months
Deepanshu Rao and Champa Devi are mutual person
- Antriksh Buildtech Private LimitedActive 9 years 5 months
Deepanshu Rao and Champa Devi are mutual person
- Antriksh Diamond Homes Private LimitedActive 9 years 5 months
Deepanshu Rao and Champa Devi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Antriksh Pharmaceuticals?
Unlock and access historical data on people associated with Antriksh Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Antriksh Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Antriksh Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.